Save women from cervical cancer in low middle income countries and middle income countries

Abstract

low income countries (LICS) and this disparity is likely to be due to differential access to screening of cervical pre cancerous lesions, treatment facilities available in primary level and taking preventive measures with new HPV-9 vaccinesas use of Human papilloma virus vaccinations continues to be lag in the low middle income countries (LMICS). Dramatic benefits were observed from vaccinations of HPV and early cervical precancerous lesions.1 The new HPV-9 vaccine which includes 9 or more HPV types there is good chance after several decades cervical cancer screening may no longer be warranted. But that is for the high income countries. What about for LMICS and MICS like India or in West Bengal Province of India? Hundreds and millions of women are already beyond the age of adolescence and age of vaccination and remains without screening and preventive treatment due to lack of human resources like trained pathologists & laboratory technicians as resource personals and this author apprehends that some 25millions women will die of cervical cancer by next 25years in MICS and LMICS.